Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

MDEV vs RAGHX overlap: 19% of top holdings shared

Bottom line

How much do MDEV and RAGHX overlap?

19% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 11.2% of MDEV's assets and 19.8% of RAGHX's. They are substantially different portfolios, so owning both adds real diversification.

MDEV holds far more positions (51 vs 24), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

MDEVRAGHX
Weight overlap (top 25)19%
Shared holdings5
Weight in shared holdings11.2%19.8%
Total positions5124
Expense ratio0.7%1.41%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings MDEV and RAGHX have in common

Holding% of MDEV% of RAGHXOverlap
West Pharmaceutical Services Inc WST2.86%5.92%2.86%
Dexcom Inc DXCM2.16%3.05%2.16%
Thermo Fisher Scientific Inc TMO2.06%3.65%2.06%
Cooper Companies Inc (the) COO2.06%3.81%2.06%
Danaher Corp DHR2.06%3.37%2.06%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in MDEV

  1. Demant A/s — 2.70%
  2. Livanova Plc — 2.69%
  3. Baxter International Inc — 2.55%
  4. Revvity Inc — 2.54%
  5. Straumann Holding Ag — 2.53%
  6. Wuxi Apptec Co Ltd — 2.44%
  7. Waters Corp — 2.40%
  8. Edwards Lifesciences Corp — 2.38%
  9. Agilent Technologies Inc — 2.37%
  10. Olympus Corp — 2.20%
  11. Teleflex Inc — 2.19%
  12. Bio-rad Laboratories Inc — 2.16%
  13. Sysmex Corp — 2.14%
  14. Sartorius Stedim Biotech Sa — 2.13%
  15. Terumo Corp — 2.12%

Only in RAGHX

  1. Eli Lilly & Company — 14.84%
  2. Abbvie Inc — 5.52%
  3. Vertex Pharmaceuticals Inc — 5.32%
  4. Merck & Company Inc — 5.06%
  5. Unitedhealth Group Inc — 4.65%
  6. Mckesson Corp — 4.57%
  7. Mettler-toledo International Inc — 3.99%
  8. Intuitive Surgical Inc — 3.89%
  9. Amgen Inc — 3.85%
  10. Idexx Laboratories Inc — 3.77%
  11. Lumexa Imaging Holdings Inc — 3.60%
  12. Healthequity Inc — 3.47%
  13. Regeneron Pharmaceuticals Inc — 2.90%
  14. Align Technology Inc — 2.88%
  15. Steris Plc — 2.32%

Asset mix

Asset typeMDEVRAGHX
Stocks99.5%98.5%
Cash & short-term funds0.5%—

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryMDEVRAGHX
US55.8%96.2%
JP8.1%—
CH6.4%—
GB4.5%—
DK4.4%—
CN4.1%—
DE3.9%—
IE3.8%2.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do MDEV and RAGHX overlap?
About 19% by weight. 5 securities appear in both funds' top 25 holdings; they make up 11.2% of MDEV's assets and 19.8% of RAGHX's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do MDEV and RAGHX have in common?
The largest shared holdings are West Pharmaceutical Services Inc, Dexcom Inc, Thermo Fisher Scientific Inc, Cooper Companies Inc (the), Danaher Corp.
Should I own both MDEV and RAGHX?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, MDEV or RAGHX?
MDEV is broader, with 51 positions versus 24 for RAGHX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.